You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 95 No. 5, MAY 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Therapgents Agents in Rheumatic Carditis

Comparative Effects of Acetylsalicylic Acid, Corticotropin, and Cortisone

CAPT. BERTRAND L. STOLZER, MC; MAJOR HAROLD B. HOUSER, MC; CAPT. ERNEST J. CLARK, MC

AMA Arch Intern Med. 1955;95(5):677-688.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Although the symptoms of acute rheumatic fever appear to be favorably altered by a number of drugs,* the essential problems of therapy are to prevent death from acute carditis and to decrease the incidence of subsequent valvular heart disease.4 The present report compares the effect of acetylsalicylic acid (Aspirin), cortisone, and corticotropin (ACTH) on valvular heart disease as evidenced by the presence of murmurs 14 months after the onset of therapy.{dagger} A previous paper 5 concerning the same group of patients dealt with a comparison of the effects of these drugs on the acute course of rheumatic fever.

METHODS

Details of the methods employed and the population involved have been described elsewhere.5 All male airmen admitted to Warren Air Force Base Hospital who met the standard diagnostic criteria and who exhibited signs of rheumatic activity on the day treatment began were accepted for study. Each patient was assigned . . . [Full Text PDF of this Article]


Author Affiliations

U. S. A. F.; A. U. S.; U. S. A. F.

From the Streptococcal Disease Laboratory and the Medical Service, U. S. A. F. Hospital, Francis E. Warren Air Force Base, Wyoming, and the Department of Preventive Medicine, School of Medicine, Western Reserve University, Cleveland; present addresses: 423 Jenkins Building, Pittsburgh (Capt. Stolzer), and Department of Medicine, State College of Medicine, Upstate Medical Center, Syracuse, N. Y. (Major Houser).


Footnotes

This investigation was conducted under the sponsorship of the Commission on Acute Respiratory Diseases and the Commission on Streptococcal Diseases, Armed Forces Epidemiological Board, and was supported by the Offices of The Surgeon General, Departments of the Army and Air Force, Washington, D. C.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.